$831 Million is the total value of Fairmount Funds Management LLC's 20 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 52.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXSM | Sell | AXSOME THERAPEUTICS INC | $163,629,124 | -2.9% | 2,341,238 | -0.2% | 19.69% | -17.1% |
| Sell | NUVALENT INC | $112,710,119 | -7.3% | 2,451,819 | -15.0% | 13.56% | -20.9% | |
| IMGN | Sell | IMMUNOGEN INC | $94,102,625 | -17.3% | 5,929,592 | -1.7% | 11.32% | -29.4% |
| New | APOGEE THERAPEUTICS INC | $62,647,049 | – | 2,941,176 | +100.0% | 7.54% | – | |
| MRUS | Buy | MERUS N V | $44,362,115 | +13.7% | 1,881,345 | +26.9% | 5.34% | -3.0% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $42,983,125 | +333.4% | 2,474,561 | +251.3% | 5.17% | +269.9% |
| ARGX | Buy | ARGENX SEsponsored adr | $41,172,538 | +43.7% | 83,747 | +13.9% | 4.95% | +22.6% |
| COGT | COGENT BIOSCIENCES INC | $34,700,006 | -17.7% | 3,558,975 | 0.0% | 4.18% | -29.7% | |
| New | SOLENO THERAPEUTICS INC | $33,714,378 | – | 1,142,473 | +100.0% | 4.06% | – | |
| Buy | ENLIVEN THERAPEUTICS INC | $29,114,501 | -32.9% | 2,131,369 | +0.3% | 3.50% | -42.7% | |
| IMVT | New | IMMUNOVANT INC | $28,792,500 | – | 750,000 | +100.0% | 3.46% | – |
| New | RAYZEBIO INC | $27,126,269 | – | 1,221,904 | +100.0% | 3.26% | – | |
| New | DIANTHUS THERAPEUTICS INC | $26,362,636 | – | 1,928,503 | +100.0% | 3.17% | – | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $21,010,017 | -35.5% | 1,369,623 | 0.0% | 2.53% | -45.0% | |
| Sell | TYRA BIOSCIENCES INC | $19,186,140 | -20.5% | 1,393,329 | -1.7% | 2.31% | -32.2% | |
| ASTRIA THERAPEUTICS INC | $14,184,422 | -10.4% | 1,901,397 | 0.0% | 1.71% | -23.6% | ||
| TRVI | Sell | TREVI THERAPEUTICS INC | $11,255,966 | -9.3% | 5,163,287 | -0.5% | 1.35% | -22.6% |
| TERN | TERNS PHARMACEUTICALS INC | $10,261,200 | -42.5% | 2,040,000 | 0.0% | 1.24% | -50.9% | |
| DBVT | Sell | DBV TECHNOLOGIES SAsponsored adr | $9,222,364 | -31.3% | 6,781,150 | -4.0% | 1.11% | -41.3% |
| New | AEGLEA BIOTHERAPEUTICS INC | $4,635,657 | – | 378,421 | +100.0% | 0.56% | – | |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -9,460,540 | -100.0% | -0.60% | – |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -381,939 | -100.0% | -1.14% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -1,985,245 | -100.0% | -1.93% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ARGENX SE | 16 | Q3 2023 | 9.3% |
| AXSOME THERAPEUTICS INC | 15 | Q3 2023 | 24.6% |
| INSMED INC | 12 | Q3 2022 | 15.0% |
| ACADIA PHARMACEUTICALS INC | 12 | Q3 2022 | 15.5% |
| IOVANCE BIOTHERAPEUTICS INC | 12 | Q3 2022 | 9.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 7.2% |
| ENANTA PHARMACEUTICALS INC | 12 | Q3 2022 | 9.6% |
| ALLAKOS INC | 12 | Q3 2022 | 7.4% |
| AMARIN CORP PLC | 12 | Q3 2022 | 10.9% |
| VERONA PHARMA PLC | 12 | Q2 2023 | 11.9% |
View Fairmount Funds Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | June 30, 2023 | 17,230,540 | 20.0% |
| Olema Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CATABASIS PHARMACEUTICALS INC | June 17, 2021 | 4,092,166 | 5.3% |
| MIRAGEN THERAPEUTICS, INC. | January 05, 2021 | 967,671 | 20.0% |
| Unum Therapeutics Inc. | July 10, 2020 | 7,482,460 | 20.0% |
View Fairmount Funds Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-25 |
| SC 13D/A | 2024-04-25 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| SC 13D/A | 2024-04-01 |
| SC 13D/A | 2024-04-01 |
| SC 13D/A | 2024-04-01 |
| SC 13D/A | 2024-04-01 |
View Fairmount Funds Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.